A similar association between ZMPSTE24–ZMYM4 dynamics and HCC progression was found: A serum level drop of four cycles or less for the ZMPSTE24–ZMYM4 transcript in sera after treatment signaled an increased risk for HCC recurrence/progression (P = 0.03). Here, ZMYM4 is linked to hepatocellular carcinoma.